What is Novo Nordisk A/S's P/FCF Ratio?

Novo Nordisk A/S (NVO) P/FCF Ratio is 13.86x based on the latest available daily valuation data on Chartloom.

How to interpret P/FCF Ratio for Novo Nordisk A/S?

Interpreting P/FCF Ratio for Novo Nordisk A/S depends on industry, growth expectations, profitability, and peer multiples.

How do you interpret Price-to-Free Cash Flow Ratio (P/FCF)?

Often considered more reliable than P/E because cash flow is harder to manipulate than earnings.

Is a higher or lower Price-to-Free Cash Flow Ratio (P/FCF) better?

Interpretation depends on context, industry, and company strategy.

Novo Nordisk A/S

$NVO

Health Care · Pharmaceuticals

IR Run Scenarios

Browse other companiesFree AI scores and summaries for more stocks

Novo Nordisk A/S

$NVO

Health Care · Pharmaceuticals

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Novo Nordisk A/S (NVO) P/FCF Ratio: 13.86x

Market cap divided by free cash flow over the last 12 months. Shows how many dollars investors pay for each $1 of yearly cash.

Latest P/FCF Ratio

13.86x

As of Nov 3, 2026

P/FCF Ratio

All ChartsAll Valuation Charts

Explore Novo Nordisk A/S's full valuation history

Beyond P/FCF Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.

View All Valuation Charts

Recent P/FCF Ratio history

Daily readings for the most recent trading days on record.

Date	P/FCF Ratio
Nov 3, 2026	13.86x

How is P/FCF Ratio calculated?

P/FCF Ratio = Market Capitalization / Free Cash Flow (TTM)

How to interpret P/FCF Ratio

P/FCF focuses on actual cash generation rather than accounting profit.

Browse other companiesFree AI scores and summaries for more stocks

Overview Charts AI Summary Financials Valuation

Novo Nordisk A/S (NVO) P/FCF Ratio: 13.86x

Market cap divided by free cash flow over the last 12 months. Shows how many dollars investors pay for each $1 of yearly cash.

Latest P/FCF Ratio

13.86x

As of Nov 3, 2026

P/FCF Ratio

All ChartsAll Valuation Charts

Explore Novo Nordisk A/S's full valuation history

Beyond P/FCF Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.

View All Valuation Charts

Recent P/FCF Ratio history

Daily readings for the most recent trading days on record.

Date	P/FCF Ratio
Nov 3, 2026	13.86x

How is P/FCF Ratio calculated?

P/FCF Ratio = Market Capitalization / Free Cash Flow (TTM)

How to interpret P/FCF Ratio

P/FCF focuses on actual cash generation rather than accounting profit.

Often considered more reliable than P/E because cash flow is harder to manipulate than earnings.

Frequently asked questions

P/E Ratio Forward P/E Ratio EV/EBITDA All Valuation Charts

Metric definition

Read the general P/FCF Ratio definition, formula, and analyst usage guide.

P/FCF Ratio guide

Informational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.

Novo Nordisk A/S

Novo Nordisk A/S

Novo Nordisk A/S (NVO) P/FCF Ratio: 13.86x

Explore Novo Nordisk A/S's full valuation history

Novo Nordisk A/S (NVO) P/FCF Ratio: 13.86x

Explore Novo Nordisk A/S's full valuation history

What is Novo Nordisk A/S's P/FCF Ratio?

How is P/FCF Ratio calculated?

How to interpret P/FCF Ratio for Novo Nordisk A/S?

How do you interpret Price-to-Free Cash Flow Ratio (P/FCF)?

How is Price-to-Free Cash Flow Ratio (P/FCF) used in stock analysis?

Is a higher or lower Price-to-Free Cash Flow Ratio (P/FCF) better?